Viewing
Feature|Articles|November 17, 2026

The important role of midface support in undereye rejuvenation

A structure-first approach to blepharoplasty and filler yields more durable, natural results.

Undereye aging is rarely an independent lower eyelid problem, yet aesthetic practice frequently treats the tear trough as though it existed in isolation. This may translate into lower eyelid fat resection when the underlying issue lies in poor midface support, or tear trough filler placed without addressing the cheek deficiency responsible for the hollow. In both instances, treatment is directed at the visible shadow rather than the structure producing it.

This distinction is clinically significant because the tear trough is not simply a depression to fill or a fat pad to excise. Rather, it is part of the transition zone between the lower eyelid and upper cheek, known as the lid-cheek junction.1 A smooth lid-cheek transition contributes to a youthful eye, where the aesthetic gaze seeks a single continuous surface. As the face ages, a gap or shadow can form between these structures, manifesting in a deeper hollow or visible fat protrusion.

There are 2 main structures that govern the lid-cheek junction transition and contribute to a visible tear trough: the skeletal platform and retaining ligaments.

The skeletal platform

The skeletal platform of the midface, composed of the maxilla, infraorbital rim, zygoma, and zygomaticomaxillary complex, confers projection beneath the lower orbit and dictates how much support exists below the eyelid before any fat or filler is considered.2 When this structure is well projected and supportive, the orbital rim is softened, and the lower eyelid appears shortened. However, when the cheek deflates, the tear trough appears deeper, and even a normal volume of orbital fat can appear disproportionately prominent.3

Facial skeletal aging contributes directly to the erosion of this support. Certain regions of the midface skeleton, including the maxilla and orbital rim, undergo progressive resorption with age.2 This means skeletal support beneath the eyelid is not simply changing over time; it is being lost. This is why a patient can still look tired or undersupported after technically sound eyelid surgery. The eyelid has been treated, but the retruding platform beneath it has not. In fact, when the lower eyelid is already deprived of support from below, aggressive fat removal can further unmask the orbital rim, leaving the lower orbit more hollow or skeletonized rather than rejuvenated.4

The retaining ligaments

Ligaments further explain why the tear trough can look so pronounced. The tear trough and orbicularis retaining ligaments arise from the periosteum near the orbital rim and wrap around the inferior orbital margin, continuing laterally into the broader orbicularis retaining ligament.5 Because this structure is fixed to bone, it does not move the way the surrounding fat and skin do. As a result, as the midface loses volume or the overlying tissue thins, the ligaments’ attachments become a visible line rather than a smooth contour. Anatomic studies have also shown that the ligament itself loosens with age, and the distance between its upper and lower layers increases over time, deepening the groove independent of any cheek volume loss.6 Some authors argue the visibility comes less from the ligament moving, because it stays tethered to bone, and more from atrophy of the skin and fat overlying it, but in both cases, the tear trough presents as a sharp, defined line rather than a diffuse hollow.1

A comprehensive treatment plan

Taken together, these anatomical findings indicate that the midface warrants assessment before the tear trough itself is addressed. Even well-executed blepharoplasty or undereye filler can fail to hold if the midface beneath it remains unsupported. In these cases, the hollow returns or never fully resolves, not from technical error, but because the treatment addressed the visible defect without addressing the structure responsible for it.

Effective undereye rejuvenation, therefore, demands more than smoothing the visible groove; it requires addressing the structures that generate the lid-cheek transition in the first place. Whether the treatment plan is surgical or nonsurgical, midface support should generally precede direct correction of the undereye.

Surgical planning

In surgical practice, this principle redefines the objective of lower blepharoplasty, which has often been conceptualized as a subtractive operation.7 This approach remains appropriate in patients with true orbital fat pseudoherniation and robust eyelid support, but if the tear trough is also driven by ligamentous tethering and cheek volume loss, fat removal alone risks trading puffiness for hollowing.

In a review of surgical tear trough correction, Atiyeh et al found broad consensus that effective correction typically requires release of the retaining ligament complex in conjunction with volume augmentation.8 Limongi et al subsequently corroborated this concept clinically in a prospective three-dimensional study, demonstrating that midface lifting improved tear trough volume regardless of whether orbital fat was resected, repositioned, or left unaddressed.9

These findings support the conceptual shift toward understanding lower blepharoplasty as a lid-cheek contour operation rather than a fat-reduction procedure. In selected patients, the appropriate plan may combine conservative fat reduction with fat repositioning, ligament release, volume restoration, canthal support, or midface lifting, with the objective of structural restoration rather than maximal tissue removal.9-11

Nonsurgical planning

The same principle applies to nonsurgical treatment. Direct tear trough filler can be effective in appropriately selected patients, but it should not be the default first step for every patient. The lower eyelid's tissue is thin and delicate, such that even modest excesses of filler can manifest as puffiness or discoloration.12

When the midface is deficient, direct tear-trough filling often requires a small volume of product to achieve disproportionate structural work. A more durable approach begins at the cheek, restoring structural support beneath the lower eyelid before placing product directly into the trough. In a 2024 review of tear trough correction, Christodoulou et al noted that adequate midface support can reduce the volume of filler required in the tear trough itself.13 In practice, this permits a more conservative correction and, in selected patients, may eliminate the need for direct tear trough filling.

This same structural logic holds up under direct study. Bernardini et al, in a cohort of 163 patients, found that filler placed near the orbicularis retaining ligament improved the overall lid-cheek junction, including the medial tear trough and lateral infraorbital hollowing, as assessed by blinded raters, the treating physician, and the patients themselves.14 The goal is therefore not to erase the tear trough by filling it until the shadow disappears, but to restore support around the lid-cheek junction so that any direct correction can be smaller, safer, and more anatomically consistent.

Conclusion

Successful undereye rejuvenation begins with recognizing that the lower eyelid depends on the support beneath it. For surgeons, this means entering blepharoplasty with a deliberate plan for ligament management and midface support, rather than defaulting to rote fat excision. For nonsurgical injectors, this means establishing cheek and malar support before directly filling the undereye area. Once the midface is restored, more conservative and natural outcomes become achievable. Ultimately, the lower eyelid appears more youthful when the cheek beneath it fulfills its structural role, restoring a smooth transition between the undereye and the midface.

Kay Durairaj, MD, FACS
E: DrKay@BeautyByDrKay.com
Durairaj is in private practice in Pasadena, California, and is vice chair of the Department of ENT/Head and Neck Surgery at Huntington Hospital. She specializes in nonsurgical rhinoplasty, collagen biostimulators, facial contouring, and advanced longevity therapies.
Mia Kronson is an undergraduate student at Pitzer College (‘27) in Claremont, California, studying chemistry and mathematics. She works as a clinical research assistant in Durairaj’s practice. Kronson has no relevant financial disclosures.
References
  1. Haddock NT, Saadeh PB, Boutros S, Thorne CH. The tear trough and lid/cheek junction: anatomy and implications for surgical correction. Plast Reconstr Surg. 2009;123(4):1332-1340. doi:10.1097/PRS.0b013e31819f2b36
  2. Mendelson B, Wong CH. Changes in the facial skeleton with aging: implications and clinical applications in facial rejuvenation. Aesthetic Plast Surg. 2012;36(4):753-760. doi:10.1007/s00266-012-9904-3
  3. Rohrich RJ, Mahedia M, Hidalgo D, Shah N. The evolving role of blending of the lid-cheek junction in lower blepharoplasty. Plast Reconstr Surg. 2018;142(2):377-382. doi:10.1097/PRS.0000000000004593
  4. Atiyeh B, Chrabieh E, Makkawi K, Beaineh P, Issa O, Emsieh S. Transconjunctival or transcutaneous approach for fat-preserving lower lid blepharoplasty? Plast Reconstr Surg Glob Open. 2025;13(12):e7345. doi:10.1097/GOX.0000000000007345
  5. Muzaffar AR, Mendelson BC, Adams WP Jr. Surgical anatomy of the ligamentous attachments of the lower lid and lateral canthus. Plast Reconstr Surg. 2002;110(3):873-884; discussion 897-911. doi:10.1097/00006534-200209010-00025
  6. Wong CH, Mendelson B. Newer understanding of specific anatomic targets in the aging face as applied to injectables: aging changes in the craniofacial skeleton and facial ligaments. Plast Reconstr Surg. 2015;136(5 suppl):44S-48S. doi:10.1097/PRS.0000000000001752
  7. Murri M, Hamill EB, Hauck MJ, Marx DP. An update on lower lid blepharoplasty. Semin Plast Surg. 2017;31(1):46-50. doi:10.1055/s-0037-1598632
  8. Atiyeh B, Hakim CR, Oneisi A, Ghieh F, Chahine F. Surgical correction of tear trough deformity (TTD) with orbicularis retaining ligament release and volume augmentation for periorbital rejuvenation: review of the literature. Aesthetic Plast Surg. 2023;47(1):199-214. doi:10.1007/s00266-022-03183-0
  9. Limongi RM, Figueiredo MN, Tao JP. Three-dimensional analysis of tear trough volume after lower blepharoplasty with midface lift. Facial Plast Surg Aesthet Med. 2023;25(6):494-499. doi:10.1089/fpsam.2022.0330
  10. Rohrich RJ, Ghavami A, Mojallal A. The five-step lower blepharoplasty: blending the eyelid-cheek junction. Plast Reconstr Surg. 2011;128(3):775-783. doi:10.1097/PRS.0b013e3182121618
  11. Hidalgo DA. An integrated approach to lower blepharoplasty. Plast Reconstr Surg. 2011;127(1):386-395. doi:10.1097/PRS.0b013e3181f95c66
  12. Zein M, Tie-Shue R, Pirakitikulr N, Lee WW. Complications after cosmetic periocular filler: prevention and management. Plast Aesthet Res. 2020;7:44. doi:10.20517/2347-9264.2020.133
  13. Christodoulou S, Tzamalis A, Tsinopoulos I, Ziakas N. Surgical and non-surgical approach for tear trough correction: fat repositioning versus hyaluronic acid fillers. J Pers Med. 2024;14(11):1096. doi:10.3390/jpm14111096
  14. Bernardini FP, Casabona G, Alfertshofer MG, et al. Soft tissue filler augmentation of the orbicularis retaining ligament to improve the lid-cheek junction. J Cosmet Dermatol. 2021;20(11):3446-3453. doi:10.1111/jocd.14495

Related to this article